'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.
Magdalena HarrisR BrathwaiteCatherine R McGowanD CiccaroneG GilchristM McCuskerK O'BrienJ DunnJ ScottV HopePublished in: Harm reduction journal (2018)
Care and Prevent is the first study to assess screening feasibility and the prevalence of positive proteinuria, as a marker for AA amyloidosis, among PWID accessing drug treatment services. AA amyloidosis is a serious, yet under-recognised condition for which early intervention is available but not employed.